FDA approves immune checkpoint inhibitor drug for patients with resectable locally advanced head and neck cancer, backed by Dana-Farber research - EurekAlert!
Immunotherapy improves survival of patients with locally advanced head and neck cancer: « Approved drug that revolutionized melanoma treatment may change standard of care for yet another cancer type. »
